Kirkland & Ellis counseled Orion Biotech Opportunities Corp. on the deal.Orion Biotech Opportunities Corp. closed its initial public offering (IPO) of 20,000,000 units at a price of $10…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
